NanoVibronix, Inc. is a medical device company. The Company develops medical devices utilizing its patented low intensity surface acoustic wave technology. Its products include UroShield and PainShield. UroShield is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy and decrease pain and discomfort associated with urinary catheter use. UroShield Ultra is similar to UroShield, but is designed to prevent bacterial colonization and biofilm formation in urinary catheters. PainShield is a patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures by delivering a localized ultrasound effect to treat pain and induce soft tissue healing in a targeted area. Its PainShield family of products includes PainShield MD, PainShield Plus and WoundShield. WoundShield is a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing.
BörsenkürzelNAOV
Name des UnternehmensNanovibronix Inc
IPO-datumApr 24, 2015
CEODr. Doron Besser, M.D.
Anzahl der mitarbeiter15
WertpapierartOrdinary Share
GeschäftsjahresendeApr 24
Addresse969 Pruitt Piace
StadtTYLER
BörseNASDAQ Capital Market Consolidated
LandUnited States of America
Postleitzahl75703
Telefon19142333004
Websitehttps://nanovibronix.com/
BörsenkürzelNAOV
IPO-datumApr 24, 2015
CEODr. Doron Besser, M.D.
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.

Keine Daten